Cresset Asset Management’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.67M | Buy |
9,426
+690
| +8% | +$268K | 0.02% | 418 |
|
2025
Q1 | $3.8M | Sell |
8,736
-488
| -5% | -$212K | 0.02% | 393 |
|
2024
Q4 | $3.4M | Sell |
9,224
-32,802
| -78% | -$12.1M | 0.02% | 413 |
|
2024
Q3 | $21.9M | Buy |
42,026
+488
| +1% | +$254K | 0.08% | 158 |
|
2024
Q2 | $22.5M | Buy |
41,538
+3,231
| +8% | +$1.75M | 0.09% | 147 |
|
2024
Q1 | $19.9M | Buy |
38,307
+1,246
| +3% | +$646K | 0.1% | 145 |
|
2023
Q4 | $17.5M | Buy |
37,061
+3,544
| +11% | +$1.67M | 0.1% | 132 |
|
2023
Q3 | $14.6M | Buy |
33,517
+8,718
| +35% | +$3.8M | 0.06% | 139 |
|
2023
Q2 | $11M | Buy |
24,799
+19,929
| +409% | +$8.85M | 0.01% | 165 |
|
2023
Q1 | $2.24M | Sell |
4,870
-5
| -0.1% | -$2.3K | 0.04% | 215 |
|
2022
Q4 | $2.48M | Sell |
4,875
-685
| -12% | -$349K | 0.03% | 181 |
|
2022
Q3 | $2.53M | Buy |
5,560
+340
| +7% | +$154K | 0.03% | 190 |
|
2022
Q2 | $2.51M | Sell |
5,220
-2,095
| -29% | -$1.01M | 0.03% | 196 |
|
2022
Q1 | $3.59M | Sell |
7,315
-1,212
| -14% | -$595K | 0.04% | 164 |
|
2021
Q4 | $3.95M | Buy |
8,527
+607
| +8% | +$281K | 0.04% | 175 |
|
2021
Q3 | $2.95M | Buy |
7,920
+609
| +8% | +$227K | 0.04% | 166 |
|
2021
Q2 | $2.79M | Buy |
7,311
+6,103
| +505% | +$2.33M | 0.04% | 160 |
|
2021
Q1 | $434K | Sell |
1,208
-5,875
| -83% | -$2.11M | 0.01% | 526 |
|
2020
Q4 | $2.27M | Sell |
7,083
-575
| -8% | -$185K | 0.04% | 149 |
|
2020
Q3 | $2.06M | Buy |
7,658
+562
| +8% | +$151K | 0.04% | 158 |
|
2020
Q2 | $1.87M | Buy |
7,096
+5,420
| +323% | +$1.43M | 0.04% | 155 |
|
2020
Q1 | $381K | Buy |
1,676
+710
| +73% | +$161K | 0.01% | 340 |
|
2019
Q4 | $292K | Buy |
+966
| New | +$292K | 0.01% | 438 |
|
2019
Q2 | – | Sell |
-598
| Closed | -$172K | – | 823 |
|
2019
Q1 | $172K | Buy |
598
+183
| +44% | +$52.6K | 0.01% | 411 |
|
2018
Q4 | $109K | Buy |
+415
| New | +$109K | 0.01% | 311 |
|